2024 Q2 Form 10-Q Financial Statement

#000107997324000549 Filed on April 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $15.90M $8.229M
YoY Change -16.1% 1.05%
Cost Of Revenue $12.94M $6.165M
YoY Change -10.92% -0.94%
Gross Profit $2.951M $2.065M
YoY Change -33.13% 7.5%
Gross Profit Margin 18.56% 25.09%
Selling, General & Admin $1.026M $2.700M
YoY Change -66.49% 146.34%
% of Gross Profit 34.77% 130.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $79.41K $91.04K
YoY Change -20.56% 3.36%
% of Gross Profit 2.69% 4.41%
Operating Expenses $2.895M $2.791M
YoY Change -8.44% -10.84%
Operating Profit $55.60K -$726.7K
YoY Change -95.56% -39.95%
Interest Expense -$1.440K $19.82K
YoY Change -99.06% -82.69%
% of Operating Profit -2.59%
Other Income/Expense, Net $13.00 $0.00
YoY Change -100.0%
Pretax Income $55.61K -$707.4K
YoY Change -94.94% -46.59%
Income Tax $99.25K -$173.3K
% Of Pretax Income 178.49%
Net Earnings $154.9K -$534.2K
YoY Change -78.93% -45.05%
Net Earnings / Revenue 0.97% -6.49%
Basic Earnings Per Share $0.04 -$0.15
Diluted Earnings Per Share $0.04 -$0.15
COMMON SHARES
Basic Shares Outstanding 3.505M shares 3.505M shares
Diluted Shares Outstanding 3.505M shares 3.504M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.055M $1.149M
YoY Change -61.17% 328.23%
Cash & Equivalents $1.055M $1.149M
Short-Term Investments
Other Short-Term Assets $1.402M $796.4K
YoY Change 61.18% -20.58%
Inventory $13.47M $17.58M
Prepaid Expenses $1.402M $796.4K
Receivables $7.408M $4.676M
Other Receivables $0.00 $0.00
Total Short-Term Assets $23.34M $24.20M
YoY Change -26.26% -15.42%
LONG-TERM ASSETS
Property, Plant & Equipment $4.482M $4.451M
YoY Change -5.56% -9.74%
Goodwill
YoY Change
Intangibles $112.4K $112.6K
YoY Change -16.35% 243.18%
Long-Term Investments
YoY Change
Other Assets $396.8K $226.2K
YoY Change 1.34% -43.18%
Total Long-Term Assets $4.991M $4.790M
YoY Change -5.32% -10.67%
TOTAL ASSETS
Total Short-Term Assets $23.34M $24.20M
Total Long-Term Assets $4.991M $4.790M
Total Assets $28.33M $28.99M
YoY Change -23.27% -14.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $787.6K $2.190M
YoY Change -70.07% 208.38%
Accrued Expenses $2.254M $1.739M
YoY Change -3.33% 2.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.286M $4.102M
YoY Change -74.93% -62.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.286M $4.102M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.286M $4.102M
YoY Change -74.93% -62.38%
SHAREHOLDERS EQUITY
Retained Earnings $23.42M $23.26M
YoY Change 5.41% 8.3%
Common Stock $826.9K $826.9K
YoY Change 0.17% 0.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.04M $24.89M
YoY Change
Total Liabilities & Shareholders Equity $28.33M $28.99M
YoY Change -23.27% -14.67%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $154.9K -$534.2K
YoY Change -78.93% -45.05%
Depreciation, Depletion And Amortization $79.41K $91.04K
YoY Change -20.56% 3.36%
Cash From Operating Activities $14.48K -$2.412M
YoY Change -99.51% 14.4%
INVESTING ACTIVITIES
Capital Expenditures $110.5K
YoY Change -228.55%
Acquisitions
YoY Change
Other Investing Activities $1.450K $3.500K
YoY Change -101.41%
Cash From Investing Activities -$109.1K $3.500K
YoY Change 560.75% -101.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities 14.48K -2.412M
Cash From Investing Activities -109.1K 3.500K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -94.61K -2.409M
YoY Change -103.87% 63.41%
FREE CASH FLOW
Cash From Operating Activities $14.48K -$2.412M
Capital Expenditures $110.5K
Free Cash Flow -$96.06K
YoY Change -103.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Income
OtherIncome
usd
CY2024Q1 us-gaap Other Income
OtherIncome
usd
CY2023Q1 us-gaap Other Income
OtherIncome
usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
jctcf Writedown Of Intangible Assets
WritedownOfIntangibleAssets
usd
jctcf Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2024Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
CY2024Q1 jctcf Agricultural Seed Products
AgriculturalSeedProducts
usd
us-gaap Capital Expenditure Discontinued Operations
CapitalExpenditureDiscontinuedOperations
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-114530 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12964 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-201082 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-568 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
89087 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-707436 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1324615 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1036140 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1417965 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-365508 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1020411 usd
jctcf Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
-825 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
105199 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
301681 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
105199 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-301681 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-1259259 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
1500000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1259259 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1500000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1065620 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-216074 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83696 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
484463 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zg6g9Az0eaR4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrkjpRV2C9N1">Estimates</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates incorporated into the Company’s consolidated financial statements include the estimated useful lives for depreciable and amortizable assets, the estimated allowances for doubtful accounts receivable and inventory obsolescence, possible product liability and possible product returns, and litigation contingencies and claims. Actual results could differ from those estimates.</span></p>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1149316 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1149316 usd
CY2024Q1 jctcf Pet Fencing And Other Products
PetFencingAndOtherProducts
16817367 usd
CY2023Q3 jctcf Pet Fencing And Other Products
PetFencingAndOtherProducts
17741254 usd
CY2024Q1 jctcf Industrial Wood Products
IndustrialWoodProducts
759430 usd
CY2023Q3 jctcf Industrial Wood Products
IndustrialWoodProducts
584989 usd
CY2023Q3 jctcf Agricultural Seed Products
AgriculturalSeedProducts
12805 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
17576787 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
18339048 usd
CY2024Q1 jctcf Office Equipment
OfficeEquipment
668260 usd
CY2023Q3 jctcf Office Equipment
OfficeEquipment
668260 usd
CY2024Q1 jctcf Warehouse Equipment
WarehouseEquipment
1382616 usd
CY2023Q3 jctcf Warehouse Equipment
WarehouseEquipment
1556424 usd
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6209162 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6209162 usd
CY2024Q1 us-gaap Land
Land
559065 usd
CY2023Q3 us-gaap Land
Land
559065 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8992911 usd
CY2024Q1 jctcf Accumulated Depreciation Property Plant And Equipment
AccumulatedDepreciationPropertyPlantAndEquipment
-4368315 usd
CY2023Q3 jctcf Accumulated Depreciation Property Plant And Equipment
AccumulatedDepreciationPropertyPlantAndEquipment
-4337484 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4450788 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4655427 usd
CY2024Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
131405 usd
CY2023Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
153195 usd
CY2024Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
18766 usd
CY2023Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
18350 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
112639 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134845 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
226148 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
319875 usd
us-gaap Pension Contributions
PensionContributions
238967 usd
us-gaap Pension Contributions
PensionContributions
276780 usd
us-gaap Revenues
Revenues
18035033 usd
us-gaap Revenues
Revenues
20720921 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1036140 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1417965 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
28988388 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
33973830 usd
us-gaap Capital Expenditure Discontinued Operations
CapitalExpenditureDiscontinuedOperations
301681 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
188943 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
199615 usd
jctcf Sales
Sales
11344309 usd
jctcf Sales
Sales
12630634 usd
jctcf Concentration Volume Of Purchases
ConcentrationVolumeOfPurchases
10143882 usd
jctcf Concentration Volume Of Purchases
ConcentrationVolumeOfPurchases
9895011 usd
us-gaap Interest Paid Net
InterestPaidNet
31183 usd
us-gaap Interest Paid Net
InterestPaidNet
186906 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
173717 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
2450000 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-000549-index-headers.html Edgar Link pending
0001079973-24-000549-index.html Edgar Link pending
0001079973-24-000549.txt Edgar Link pending
0001079973-24-000549-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jctcf-20240229.xsd Edgar Link pending
jctcf_ex31x1.htm Edgar Link pending
jctcf_ex31x2.htm Edgar Link pending
jctcf_ex32x1.htm Edgar Link pending
jctcf_ex32x2.htm Edgar Link pending
jctc_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
jctcf-20240229_cal.xml Edgar Link unprocessable
jctcf-20240229_def.xml Edgar Link unprocessable
jctcf-20240229_lab.xml Edgar Link unprocessable
jctcf-20240229_pre.xml Edgar Link unprocessable
jctc_10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable